Emerging antiretroviral drug resistance in sub-Saharan Africa: novel affordable technologies are needed to provide resistance testing for individual and public health benefits.
Identifieur interne : 003215 ( Main/Merge ); précédent : 003214; suivant : 003216Emerging antiretroviral drug resistance in sub-Saharan Africa: novel affordable technologies are needed to provide resistance testing for individual and public health benefits.
Auteurs : Gert U. Van Zyl [États-Unis] ; Lisa M. Frenkel ; Michael H. Chung ; Wolfgang Preiser ; John W. Mellors ; Jean B. NachegaSource :
- AIDS (London, England) [ 1473-5571 ] ; 2014.
Descripteurs français
- KwdFr :
- Afrique subsaharienne, Antirétroviraux (pharmacologie), Antirétroviraux (usage thérapeutique), Humains, Incidence, Infections à VIH (traitement médicamenteux), Infections à VIH (virologie), Résistance virale aux médicaments, Tests de sensibilité microbienne (), Tests de sensibilité microbienne (utilisation), VIH (Virus de l'Immunodéficience Humaine) (), VIH (Virus de l'Immunodéficience Humaine) (isolement et purification).
- MESH :
- isolement et purification : VIH (Virus de l'Immunodéficience Humaine).
- pharmacologie : Antirétroviraux.
- traitement médicamenteux : Infections à VIH.
- usage thérapeutique : Antirétroviraux.
- utilisation : Tests de sensibilité microbienne.
- virologie : Infections à VIH.
- Afrique subsaharienne, Humains, Incidence, Résistance virale aux médicaments, Tests de sensibilité microbienne, VIH (Virus de l'Immunodéficience Humaine).
English descriptors
- KwdEn :
- Africa South of the Sahara, Anti-Retroviral Agents (pharmacology), Anti-Retroviral Agents (therapeutic use), Drug Resistance, Viral, HIV (drug effects), HIV (isolation & purification), HIV Infections (drug therapy), HIV Infections (virology), Humans, Incidence, Microbial Sensitivity Tests (methods), Microbial Sensitivity Tests (utilization).
- MESH :
- chemical , pharmacology : Anti-Retroviral Agents.
- chemical , therapeutic use : Anti-Retroviral Agents.
- geographic : Africa South of the Sahara.
- drug effects : HIV.
- drug therapy : HIV Infections.
- isolation & purification : HIV.
- methods : Microbial Sensitivity Tests.
- utilization : Microbial Sensitivity Tests.
- virology : HIV Infections.
- Drug Resistance, Viral, Humans, Incidence.
DOI: 10.1097/QAD.0000000000000502
PubMed: 25493592
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 001023
- to stream PubMed, to step Curation: 001019
- to stream PubMed, to step Checkpoint: 001019
- to stream Ncbi, to step Merge: 004374
- to stream Ncbi, to step Curation: 004374
- to stream Ncbi, to step Checkpoint: 004374
Links to Exploration step
pubmed:25493592Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Emerging antiretroviral drug resistance in sub-Saharan Africa: novel affordable technologies are needed to provide resistance testing for individual and public health benefits.</title><author><name sortKey="Van Zyl, Gert U" sort="Van Zyl, Gert U" uniqKey="Van Zyl G" first="Gert U" last="Van Zyl">Gert U. Van Zyl</name><affiliation wicri:level="2"><nlm:affiliation>aDivision of Medical Virology, Department of Pathology, Stellenbosch University and National Health Laboratory Service Tygerberg, Cape Town, South Africa bDepartments of Pediatrics, Laboratory Medicine and Global Health, University of Washington, and Seattle Children's Research Institute cDepartments of Global Health, Medicine, and Epidemiology, University of Washington, Seattle, Washington, USA dDepartment of Medicine and Center for Infectious Diseases, Stellenbosch University Faculty of Medicine and Health Sciences, Cape Town, South Africa eDepartments of International Health and Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland fDivision of Infectious Diseases, Department of Medicine gDepartment of Epidemiology, Pittsburgh School of Medicine and Graduate School of Public Health, Pittsburgh, Pennsylvania, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>aDivision of Medical Virology, Department of Pathology, Stellenbosch University and National Health Laboratory Service Tygerberg, Cape Town, South Africa bDepartments of Pediatrics, Laboratory Medicine and Global Health, University of Washington, and Seattle Children's Research Institute cDepartments of Global Health, Medicine, and Epidemiology, University of Washington, Seattle, Washington, USA dDepartment of Medicine and Center for Infectious Diseases, Stellenbosch University Faculty of Medicine and Health Sciences, Cape Town, South Africa eDepartments of International Health and Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland fDivision of Infectious Diseases, Department of Medicine gDepartment of Epidemiology, Pittsburgh School of Medicine and Graduate School of Public Health, Pittsburgh, Pennsylvania</wicri:regionArea><placeName><region type="state">Pennsylvanie</region></placeName></affiliation></author><author><name sortKey="Frenkel, Lisa M" sort="Frenkel, Lisa M" uniqKey="Frenkel L" first="Lisa M" last="Frenkel">Lisa M. Frenkel</name></author><author><name sortKey="Chung, Michael H" sort="Chung, Michael H" uniqKey="Chung M" first="Michael H" last="Chung">Michael H. Chung</name></author><author><name sortKey="Preiser, Wolfgang" sort="Preiser, Wolfgang" uniqKey="Preiser W" first="Wolfgang" last="Preiser">Wolfgang Preiser</name></author><author><name sortKey="Mellors, John W" sort="Mellors, John W" uniqKey="Mellors J" first="John W" last="Mellors">John W. Mellors</name></author><author><name sortKey="Nachega, Jean B" sort="Nachega, Jean B" uniqKey="Nachega J" first="Jean B" last="Nachega">Jean B. Nachega</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2014">2014</date><idno type="RBID">pubmed:25493592</idno><idno type="pmid">25493592</idno><idno type="doi">10.1097/QAD.0000000000000502</idno><idno type="wicri:Area/PubMed/Corpus">001023</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001023</idno><idno type="wicri:Area/PubMed/Curation">001019</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001019</idno><idno type="wicri:Area/PubMed/Checkpoint">001019</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001019</idno><idno type="wicri:Area/Ncbi/Merge">004374</idno><idno type="wicri:Area/Ncbi/Curation">004374</idno><idno type="wicri:Area/Ncbi/Checkpoint">004374</idno><idno type="wicri:Area/Main/Merge">003215</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Emerging antiretroviral drug resistance in sub-Saharan Africa: novel affordable technologies are needed to provide resistance testing for individual and public health benefits.</title><author><name sortKey="Van Zyl, Gert U" sort="Van Zyl, Gert U" uniqKey="Van Zyl G" first="Gert U" last="Van Zyl">Gert U. Van Zyl</name><affiliation wicri:level="2"><nlm:affiliation>aDivision of Medical Virology, Department of Pathology, Stellenbosch University and National Health Laboratory Service Tygerberg, Cape Town, South Africa bDepartments of Pediatrics, Laboratory Medicine and Global Health, University of Washington, and Seattle Children's Research Institute cDepartments of Global Health, Medicine, and Epidemiology, University of Washington, Seattle, Washington, USA dDepartment of Medicine and Center for Infectious Diseases, Stellenbosch University Faculty of Medicine and Health Sciences, Cape Town, South Africa eDepartments of International Health and Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland fDivision of Infectious Diseases, Department of Medicine gDepartment of Epidemiology, Pittsburgh School of Medicine and Graduate School of Public Health, Pittsburgh, Pennsylvania, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>aDivision of Medical Virology, Department of Pathology, Stellenbosch University and National Health Laboratory Service Tygerberg, Cape Town, South Africa bDepartments of Pediatrics, Laboratory Medicine and Global Health, University of Washington, and Seattle Children's Research Institute cDepartments of Global Health, Medicine, and Epidemiology, University of Washington, Seattle, Washington, USA dDepartment of Medicine and Center for Infectious Diseases, Stellenbosch University Faculty of Medicine and Health Sciences, Cape Town, South Africa eDepartments of International Health and Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland fDivision of Infectious Diseases, Department of Medicine gDepartment of Epidemiology, Pittsburgh School of Medicine and Graduate School of Public Health, Pittsburgh, Pennsylvania</wicri:regionArea><placeName><region type="state">Pennsylvanie</region></placeName></affiliation></author><author><name sortKey="Frenkel, Lisa M" sort="Frenkel, Lisa M" uniqKey="Frenkel L" first="Lisa M" last="Frenkel">Lisa M. Frenkel</name></author><author><name sortKey="Chung, Michael H" sort="Chung, Michael H" uniqKey="Chung M" first="Michael H" last="Chung">Michael H. Chung</name></author><author><name sortKey="Preiser, Wolfgang" sort="Preiser, Wolfgang" uniqKey="Preiser W" first="Wolfgang" last="Preiser">Wolfgang Preiser</name></author><author><name sortKey="Mellors, John W" sort="Mellors, John W" uniqKey="Mellors J" first="John W" last="Mellors">John W. Mellors</name></author><author><name sortKey="Nachega, Jean B" sort="Nachega, Jean B" uniqKey="Nachega J" first="Jean B" last="Nachega">Jean B. Nachega</name></author></analytic><series><title level="j">AIDS (London, England)</title><idno type="eISSN">1473-5571</idno><imprint><date when="2014" type="published">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Africa South of the Sahara</term><term>Anti-Retroviral Agents (pharmacology)</term><term>Anti-Retroviral Agents (therapeutic use)</term><term>Drug Resistance, Viral</term><term>HIV (drug effects)</term><term>HIV (isolation & purification)</term><term>HIV Infections (drug therapy)</term><term>HIV Infections (virology)</term><term>Humans</term><term>Incidence</term><term>Microbial Sensitivity Tests (methods)</term><term>Microbial Sensitivity Tests (utilization)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Afrique subsaharienne</term><term>Antirétroviraux (pharmacologie)</term><term>Antirétroviraux (usage thérapeutique)</term><term>Humains</term><term>Incidence</term><term>Infections à VIH (traitement médicamenteux)</term><term>Infections à VIH (virologie)</term><term>Résistance virale aux médicaments</term><term>Tests de sensibilité microbienne ()</term><term>Tests de sensibilité microbienne (utilisation)</term><term>VIH (Virus de l'Immunodéficience Humaine) ()</term><term>VIH (Virus de l'Immunodéficience Humaine) (isolement et purification)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Anti-Retroviral Agents</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-Retroviral Agents</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>Africa South of the Sahara</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>HIV</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>HIV Infections</term></keywords><keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>HIV</term></keywords><keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>VIH (Virus de l'Immunodéficience Humaine)</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Microbial Sensitivity Tests</term></keywords><keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Antirétroviraux</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Infections à VIH</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antirétroviraux</term></keywords><keywords scheme="MESH" qualifier="utilisation" xml:lang="fr"><term>Tests de sensibilité microbienne</term></keywords><keywords scheme="MESH" qualifier="utilization" xml:lang="en"><term>Microbial Sensitivity Tests</term></keywords><keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Infections à VIH</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>HIV Infections</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Drug Resistance, Viral</term><term>Humans</term><term>Incidence</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Afrique subsaharienne</term><term>Humains</term><term>Incidence</term><term>Résistance virale aux médicaments</term><term>Tests de sensibilité microbienne</term><term>VIH (Virus de l'Immunodéficience Humaine)</term></keywords></textClass></profileDesc></teiHeader></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Amérique/explor/PittsburghV1/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003215 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 003215 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Amérique
|area= PittsburghV1
|flux= Main
|étape= Merge
|type= RBID
|clé= pubmed:25493592
|texte= Emerging antiretroviral drug resistance in sub-Saharan Africa: novel affordable technologies are needed to provide resistance testing for individual and public health benefits.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/RBID.i -Sk "pubmed:25493592" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Merge/biblio.hfd \
| NlmPubMed2Wicri -a PittsburghV1
| This area was generated with Dilib version V0.6.38. |  |